Inici › Mieloma múltiple › Washington › Tacoma
Assaigs clínics de Mieloma múltiple a Tacoma, WA
13 estudis de Mieloma múltiple busquen participants en centres de Tacoma i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
ReclutantFase 3
- Study Site 103, Tacoma
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
ReclutantFase 3
- Research Site, Puyallup · a 8 mi
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 3
- NorthWest Medical Specialties, PLLC, Tacoma
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
ReclutantFase 4
- Northwest Medical Specialties, PLLC, Tacoma
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ReclutantFase 3
- NorthWest Medical Specialties, PLLC, Tacoma
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
ReclutantFase 1
- American Oncology Network Vista Oncology Division / Physician partner associate, Olympia · a 26 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutantFase 2
- Northwest Medical Specialties, Tacoma
- Northwest Medical Specialties, Gig Harbor · a 8 mi
- Northwest Medical Specialties, Puyallup · a 8 mi
- i 1 més
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
ReclutantFase 1/2
- Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
ReclutantFase 1
- Northwest Medical Specialties, Tacoma
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ReclutantFase 3
- Research Site, Puyallup · a 8 mi
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 1
- Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ReclutantFase 3
- Providence Regional Cancer System-Yelm, Yelm · a 23 mi
- Providence Regional Cancer System-Lacey, Lacey · a 23 mi
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
ReclutantFase 3
- GSK Investigational Site, Puyallup · a 8 mi
Assaigs de Mieloma múltiple en altres ciutats
- New York City, NY60 estudis
- Boston, MA42 estudis
- Atlanta, GA41 estudis
- Houston, TX38 estudis
- Durham, NC37 estudis
- Nashville, TN32 estudis
- Denver, CO27 estudis
- Rochester, MN24 estudis
- St. Louis, MO24 estudis
- Columbus, OH24 estudis
- Baldwin Park, CA23 estudis
- Chicago, IL22 estudis
Altres estudis a Tacoma
- Càncer de pulmó de cèl·lules no petites20 estudis
- Càncer de mama18 estudis
- Colitis ulcerosa15 estudis
- Càncer de pròstata11 estudis
- Malaltia de Crohn11 estudis
- Càncer metastàtic9 estudis
- Càncer colorrectal9 estudis
- Melanoma7 estudis
- Càncer d'ovari7 estudis
- Càncer (tots els tipus)6 estudis
- Càncer de pàncrees6 estudis
- Obesitat6 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.